Document ID: chunk:federal_register_of_legislation:F2021L00352:reg:9:p2
Version: federal_register_of_legislation:F2021L00352
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 6594–8207

to maintain personal hygiene include severe injuries, paralysis, immobility, alcohol use disorder and major depressive disorder.
(13)      being immobile for at least the four weeks before the clinical worsening of seborrhoeic dermatitis;
            Note: Examples of being immobile include being in intensive care, having a spinal cord injury and, for facial seborrhoeic dermatitis, having facial paralysis.
(14)      having received a solid organ transplant at the time of the clinical worsening of seborrhoeic dermatitis;
(15)      taking a drug from the specified list of drugs for the treatment of cancer or autoimmune disease for at least the seven days before the clinical worsening of seborrhoeic dermatitis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(16)      taking a drug which is associated in the individual with the clinical worsening of seborrhoeic dermatitis during drug therapy and either:
(a)           the improvement of seborrhoeic dermatitis within three months of discontinuing or tapering drug therapy; or
(b)          the worsening of seborrhoeic dermatitis on rechallenge with the same drug; and
where taking the drug continued for at least the seven days before the clinical worsening of seborrhoeic dermatitis;
(17)      wearing a surgical mask or face covering intended to provide protection from human-to-human respiratory virus transmission, for a cumulative period of at least 20 hours in the seven days before the clinical worsening of seborrhoeic dermatitis;
(18)      inability to obtain appropriate clinical management for seborrhoeic dermatitis.